531015 VENMAX

Venmax Drugs & Pharmaceuticals Share Price

₹16.38 +0.78 (5%)

28 Dec, 2024 01:31

SIP TrendupStart SIP in VENMAX

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 291.87%
  • Over 3 Month + 291.87%
  • Over 6 Month + 291.87%
  • Over 1 Year + 291.87%
SIP Lightning

Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Venmax Drugs & Pharmaceuticals Financials

Venmax Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹16.38
+ 0.78 (5%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹10.63
  • 50 Day
  • ₹7.34
  • 100 Day
  • ₹5.55
  • 200 Day
  • ₹4.84

Resistance and Support

16.38 Pivot Speed
  • R3 16.38
  • R2 16.38
  • R1 16.38
  • S1 16.38
  • S2 16.38
  • S3 16.38

What's your outlook on Venmax Drugs & Pharmaceuticals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

N/A

Group Rank

Venmax Dg.And Pharms. has an operating revenue of Rs. 0.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -52% needs improvement, Pre-tax margin of 0% needs improvement, ROE of -9% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 99 which is GREAT indicating the outperformance as compared to other stocks, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has some relative strength but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-08-12 Quarterly Results
2024-05-14 Audited Results
2024-01-30 Quarterly Results
2023-11-14 Quarterly Results

Venmax Drugs & Pharmaceuticals F&O

Venmax Drugs & Pharmaceuticals Shareholding Pattern

23.13%
0.15%
65.68%
11.04%

About Venmax Drugs & Pharmaceuticals

  • NSE Symbol
  • VENMAX
  • BSE Symbol
  • 531015
  • Managing Director
  • Mr. N Krishnaiah
  • ISIN
  • INE154G01022

Similar Stocks to Venmax Drugs & Pharmaceuticals

Venmax Drugs & Pharmaceuticals FAQs

Venmax Drugs & Pharmaceuticals share price is ₹16 As on 28 December, 2024 | 01:17

The Market Cap of Venmax Drugs & Pharmaceuticals is ₹8.6 Cr As on 28 December, 2024 | 01:17

The P/E ratio of Venmax Drugs & Pharmaceuticals is -39.2 As on 28 December, 2024 | 01:17

The PB ratio of Venmax Drugs & Pharmaceuticals is -13.2 As on 28 December, 2024 | 01:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23